Using a new antiallergic drug Epinepta® in the treatment of seasonal allergic conjunctivitis. Clinical cases

Purpose: to evaluate the effect of a new antiallergic drug epinastine in the treatment of seasonal conjunctivitis as manifested in clinical cases.Materials and methods. 37 people (22 men and 15 women) were observed during spring exacerbation of the allergic conjunctivitis, from mid-March to the end...

Full description

Saved in:
Bibliographic Details
Main Author: E. V. Yani
Format: Article
Language:Russian
Published: Real Time Ltd 2023-12-01
Series:Российский офтальмологический журнал
Subjects:
Online Access:https://roj.igb.ru/jour/article/view/1368
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849696672157794304
author E. V. Yani
author_facet E. V. Yani
author_sort E. V. Yani
collection DOAJ
description Purpose: to evaluate the effect of a new antiallergic drug epinastine in the treatment of seasonal conjunctivitis as manifested in clinical cases.Materials and methods. 37 people (22 men and 15 women) were observed during spring exacerbation of the allergic conjunctivitis, from mid-March to the end of June. Indicators of the dynamics of subjective complaints, duration of treatment, clinical effectiveness, were thoroughly recorded; we also assessed how easy it was to stop using the treatment when the condition of the ocular surface returned to normal.Results. We identified four groups of patients depending on the course of the disease, clinical manifestations, and response to epinastine therapy. For each group, we analyze a most informative clinical case.Conclusions. In all of the cases, epinastine instillations brought about a quick and stable reduction of itching and eye discomfort, as well as normalization of the clinical condition of the conjunctiva.
format Article
id doaj-art-5bbace2276de4edcaa7cb0149f55793e
institution DOAJ
issn 2072-0076
2587-5760
language Russian
publishDate 2023-12-01
publisher Real Time Ltd
record_format Article
series Российский офтальмологический журнал
spelling doaj-art-5bbace2276de4edcaa7cb0149f55793e2025-08-20T03:19:24ZrusReal Time LtdРоссийский офтальмологический журнал2072-00762587-57602023-12-0116414114610.21516/2072-0076-2023-16-4-141-146652Using a new antiallergic drug Epinepta® in the treatment of seasonal allergic conjunctivitis. Clinical casesE. V. Yani0Helmholtz National Medical Research Center of Eye DiseasesPurpose: to evaluate the effect of a new antiallergic drug epinastine in the treatment of seasonal conjunctivitis as manifested in clinical cases.Materials and methods. 37 people (22 men and 15 women) were observed during spring exacerbation of the allergic conjunctivitis, from mid-March to the end of June. Indicators of the dynamics of subjective complaints, duration of treatment, clinical effectiveness, were thoroughly recorded; we also assessed how easy it was to stop using the treatment when the condition of the ocular surface returned to normal.Results. We identified four groups of patients depending on the course of the disease, clinical manifestations, and response to epinastine therapy. For each group, we analyze a most informative clinical case.Conclusions. In all of the cases, epinastine instillations brought about a quick and stable reduction of itching and eye discomfort, as well as normalization of the clinical condition of the conjunctiva.https://roj.igb.ru/jour/article/view/1368seasonal allergic conjunctivitisepinastineepinepta
spellingShingle E. V. Yani
Using a new antiallergic drug Epinepta® in the treatment of seasonal allergic conjunctivitis. Clinical cases
Российский офтальмологический журнал
seasonal allergic conjunctivitis
epinastine
epinepta
title Using a new antiallergic drug Epinepta® in the treatment of seasonal allergic conjunctivitis. Clinical cases
title_full Using a new antiallergic drug Epinepta® in the treatment of seasonal allergic conjunctivitis. Clinical cases
title_fullStr Using a new antiallergic drug Epinepta® in the treatment of seasonal allergic conjunctivitis. Clinical cases
title_full_unstemmed Using a new antiallergic drug Epinepta® in the treatment of seasonal allergic conjunctivitis. Clinical cases
title_short Using a new antiallergic drug Epinepta® in the treatment of seasonal allergic conjunctivitis. Clinical cases
title_sort using a new antiallergic drug epinepta r in the treatment of seasonal allergic conjunctivitis clinical cases
topic seasonal allergic conjunctivitis
epinastine
epinepta
url https://roj.igb.ru/jour/article/view/1368
work_keys_str_mv AT evyani usinganewantiallergicdrugepineptainthetreatmentofseasonalallergicconjunctivitisclinicalcases